Abstract.
Nine Japanese children with severe proteinuric Henoch-Schönlein purpura nephritis (HSPN) received prompt initiation of oral prednisolone (1.5 mg/kg/day) combined with an 8-week course of cyclophosphamide (2 mg/kg/day) therapy. All underwent renal biopsy before and after treatment. At presentation, urine protein excretion and histologic indices of the mean activity index, the mean chronicity index and the tubulointerstitial (TI) scores in the patients were 5.0±1.4, 4.7±1.0, 3.9±1.6 and 3.7±0.5 g/day, respectively. Urine protein excretion, the activity index and the TI scores decreased significantly at the second renal biopsies obtained at a mean interval of 23 months after the first [0.3±0.3, 2.4±0.5 and 1.4±0.7 g/day (P<0.01), respectively], while the chronicity index did not change. At the latest observation (mean interval 78 months), all except two showed negative proteinuria while no patient showed renal impairment. Although this case series is without controls, our experience suggests that early treatment with oral prednisolone and cyclophosphamide may be beneficial to a proportion of patients with severe proteinuric HSPN.
Similar content being viewed by others
References
Austin HA, Balow JE (1983) Henoch-Schönlein nephritis: prognostic features and the challenge of therapy. Am J Kidney Dis 2:512–520
Goldstein AR, White RHR, Akuse R, Chantler C (1992) Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 339:280–282
Davin J-C, Weening JJ (2001) Henoch-Schönlein purpura nephritis: an update. Eur J Pediatr 160:689–695
Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol 12:238–243
Takemura T, Yoshioka K, Yagi K, Okada M, Murakami K, Hino S, Maki S (1993) Cocktail therapy of Henoch-Schönlein purpura nephritis (in Japanese). Syonika (Pediatr Jpn) 34:473–477
Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N (1998) Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol 12:244–248
Andreoli SP, Bergstein JM (1989) Treatment of severe IgA nephropathy in children. Pediatr Nephrol 3:248–253
Tanaka H, Waga S, Yokoyama H (1998) Age-related histologic alterations after prednisolone therapy in children with IgA nephropathy. Tohoku J Exp Med 185:247–252
Koskimies O, Mir S, Rapola J, Vilska J (1981) Henoch-Schönlein nephritis: long-term prognosis of unselected patients. Arch Dis Child 56:482–484
Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe Henoch-Schönlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370–375
Yoshikawa N, Ito H, Yoshiya K, Nakahara C, Yoshiara S, Hasegawa O, Matsuyama S, Matsuo T (1987) Henoch-Schönlein nephritis and IgA nephropathy in children: a comparison of clinical course. Clin Nephrol 27:233–237
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tanaka, H., Suzuki, K., Nakahata, T. et al. Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 18, 347–350 (2003). https://doi.org/10.1007/s00467-003-1094-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-003-1094-4